Hard pass for me on that link. I think what you're

New Post Public Reply Private Reply Replies (3) Message Board
Respert24 MGK_2 #147958
740
Hard pass for me on that link.

I think what you're feeling from ER and possibly others is the confusion of not catching any of the many gentle suggestions from actual, recognized, career writers about tidying up your billion word posts so they're more palatable. As well as the many gentle nudges from those who have made a career in biotech or the sciences to correct some glaring assumptions you continue to spin and turn and build into fanciful outcomes that aren't realistic. But nobody gets through. It happens over and over, and I think what's happening here is you're confused that you continue to get any sort of pushback because you've decided you're CYDY's pied piper?

By all means, keep doing what you're doing and never take any advice from anyone. Seriously. You can do that all you want. You're currently doing it. Honestly, it's all good. Just don't be surprised when some people aren't on board with it. Especially the ones who have tried to point out glaring issues in a post only to get a reply that basically says "well I still think I'm right".

You're running on a feedback loop fueled by confirmation bias.

And while that fuel burns, you continue to be a part of a select few who clog the boards under what appears to be the assumption that more words equals more clout. Or more intelligence, maybe? I don't know for sure.

But what I do know is that taking some criticism every once in a while, and adjusting your position based on that, isn't a weakness. It's a sign of intelligence. There are people to be learned from on this board. People who have worked in pharma/bio their entire careers in the HIV space or oncology. People who make their living improving the writing of others. People who have won countless awards writing documentaries and bump erasers with the best in the biz. Doctors, Degenerates, Dipshits. And on an on. Lots of people to learn from if you're willing to admit you might be wrong on occasion. Hell, I've been wrong plenty. Learned from my mistakes and got better for it. And I'll continue to be wrong at times, I'm sure. That's life.

At any rate, CCR5 amirite?

#Science #Leronlimab

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Chery Auto's Bold Green Tech Showcase at 2026 Summit

Updated Category News Views 1

Chery Auto Puts Eco Tech at Front and Center You know, Chery Auto isn't just manufacturing cars anymore—it's shaping an entire lifestyle. For the uninitiated, they’re calling in everyone worth knowing to their headquarters in Wuhu, China, come October 18 through 24. The 2026 Chery International User Summit is kind of a big deal this year with nearly 20 new green...

Continue Reading
Shanghai's Arts Carnival Fuses Tech and Culture

Updated Category News Views 1

Shanghai Heralds New Era in Arts with Carnival Coming in hot, Shanghai's ready to shake up the city's cultural scene with the 2026 International Audio-Visual Arts Carnival. It's happening in Jing'an District from September 24 to October 18, promising an experience that fuses travel, technology, and art. Just about anyone can catch a break from their daily grind and dive...

Continue Reading
AI Agents Challenge Product Governance Models

Updated Category News Views 7

AI's Increasing Role: A Double-Edged Sword for Leaders Hey, the tech overlords remind us once again—the future doesn't wait for anyone to catch up before it bulldozes forward. Info-Tech Research Group has sounded the alarm on AI agents muscling their way into product decisions without any clear nod from the human corner office. Blurring Lines of Accountability The...

Continue Reading
Invictus Pharmacy Secures LegitScript Certification Status

Updated Category News Views 3

A New Chapter for Invictus Pharmacy In a world tangled up in red tape, Invictus Pharmacy somehow managed to cut a clear path by earning the LegitScript Healthcare Merchant Certification. Now, it seems like they've joined the ranks of the big players, including the likes of Amazon Pharmacy. It’s not just a shiny badge on their website, folks. It’s better access to...

Continue Reading
Beta Bionics Lawsuit Deadline: Investors Face November 3 Cut-off

Updated Category News Views 4

Looming Deadline for Beta Bionics Investors Time's ticking fast for those holding onto Beta Bionics (BBNX) stock who might've been caught in a web of undisclosed risks and regulatory misses. Investors feeling the pinch from this fiasco have till November 3, 2026, to throw their hat in the ring as lead plaintiffs in the class action lawsuit out of California. The...

Continue Reading
Xi Jinping Thought: A Bold Prospect for Future Governance

Updated Category News Views 5

107 years in the game, and the Communist Party of China (CPC) isn't showing any signs of slowing. With their recent conference in Beijing focusing on Xi Jinping Thought on Party Building, it’s clear they’ve got their eyes on the future, not just resting on past laurels. This Xi Jinping Thought is about a thorough self-improvement plan for the Party, a clear strategy...

Continue Reading
No Dogs Left Behind Marks Decade of Life-Saving Work

Updated Category News Views 4

A Decade of Dedication Some stories out there bring a much-needed shine to the otherwise relentless grind, and this is one of those rare gems. No Dogs Left Behind (NDLB) is celebrating a monumental milestone: ten years into their mission, they've crossed the incredible threshold of saving over 10,000 dogs from the clutches of slaughterhouses in East Asia. The nonprofit...

Continue Reading
Heafner Takes Helm at HGTC Amid Strategic Shifts

Updated Category News Views 2

A New Era for HGTC with Dr. Heafner at the Wheel Out of the frying pan and into the fire—Dr. Lori Heafner is stepping up to lead Horry-Georgetown Technical College (HGTC) with a clean slate and a hefty load of responsibility come January 2027. After enduring an intense national search by the Area Commission, she beat out tough competition to earn the role. It's not just...

Continue Reading
Kobold Press Explores Roleplaying as Literacy Tool

Updated Category News Views 5

Gaming Illuminates Pathways to Literacy and Community Trust me, when an indie game publisher like Kobold Press makes waves, it's worth paying attention. They've carved a niche in the roleplaying world by marrying traditional game elements with valuable educational tools. The thrill of the game goes beyond rolling dice; it's a ticket to improving literacy, arithmetic, and...

Continue Reading
China's Tech Success Echoes in Global Living Rooms

Updated Category News Views 2

A New Player in Global Tech If you've been sleeping on China's tech scene, it's time to wake up. Moonshot AI just launched Kimi K3, the largest open-source model by parameters we've seen, a significant leap in artificial intelligence that's catching even the eyes of folks who hardly touch technology—like retirees in Italy. Rapid AI Advancements China's story isn't about...

Continue Reading

Top 5 Most Recently Viewed Articles

Navigating Crypto Investments Amid Global Turbulence

Updated Category News Views 160

The Impact of Global Events on Crypto Investments In today's fast-paced world, international conflicts can have immediate repercussions on global financial markets. Recent events in the Middle East have caused major fluctuations in traditional and digital currencies alike. As tensions rise, many investors seek safer havens for their assets, leading to increased interest...

Continue Reading
21Shares AG Unveils Supplementary Prospectus for Investors

Updated Category News Views 135

21Shares AG Announces Supplementary Prospectus 21Shares AG LEI: 254900UWHMJRRODS3Z64 Recently, 21Shares AG introduced a supplementary prospectus to their existing Base Prospectus. This supplement is an important update that reflects recent changes within the company's corporate structure, primarily due to their acquisition of 21co Holdings Limited by FalconX Group....

Continue Reading
Global Healthcare Cybersecurity Market Set to Soar by 2033

Updated Category News Views 193

The Growth of the Global Healthcare Cybersecurity Market The healthcare cybersecurity market is undergoing a major transformation. Initially estimated at USD 17.10 billion in 2023, it's on track to soar to USD 95.59 billion by 2033, reflecting a remarkable compound annual growth rate (CAGR) of 18.60%. This impressive growth is largely due to an alarming rise in...

Continue Reading
AVAV Stock: Analysts Bullish—But What's the Real Play?

Updated Category News Views 125

Analysts just cranked up their outlook on AeroVironment (AVAV), signaling a buy for the stock—but are they seeing something we’re missing? You know how these hype trains roll, right? Wall Street throws out ratings like confetti, but you gotta read between the lines. Let’s break down what this means for your wallet. AVAV Bullish Ratings: Surface-Level Optimism or...

Continue Reading
Renewal of Canadian Banc Corp's Equity Program Signals Growth

Updated Category News Views 142

Overview of the Renewed Equity Program Canadian Banc Corp. has recently announced the renewal of its at-the-market equity program (ATM Program), which allows the Company to issue shares to the public at its discretion. This program is effective until the specified period unless terminated earlier by the Company, focusing on executing strategic financial goals through...

Continue Reading